FDA approves Linzess (Linaclotide) for kids 7+ with IBS-C: First-ever treatment for pediatric constipation pain

The FDA has approved Linzess (linaclotide) for children aged 7 and older with IBS-C, marking the first FDA-approved drug for ...
The Brighterside of News on MSN

Mediterranean diet provides significant relief for IBS sufferers, study finds

Living with irritable bowel syndrome can often feel like a delicate balance between food and fear. One day, a simple meal ...
Medscape

Which Works Better for IBS: Rifaximin or Low-FODMAP Diet?

Rifaximin is as effective as the low-FODMAP diet in managing irritable bowel syndrome and offers quicker symptom relief and ...
Becker's Hospital Review

FDA approves IBS drug for children: 5 things to know

FDA approves IBS drug for children, Linzess, to treat pediatric IBS-C in patients ages 7 and older with proven safety and efficacy.
The Pharma Letter

FDA clears first IBS-C treatment for children

The US medicines regulator has approved Linzess (linaclotide) capsules for children aged seven years and older with irritable ...
MedPage Today on MSN

FDA Approves First Drug for Kids' Irritable Bowel Syndrome With Constipation

Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...
New Atlas

Mediterranean diet outperforms low-FODMAP plan for easing IBS symptoms

There's growing evidence that a Mediterranean diet can provide relief from symptoms of irritable bowel syndrome (IBS), ...
MedPage Today on MSN

Migraine Drug Shows Promise as IBS Treatment in Small Trial

Rimegepant is already FDA-approved for acute treatment of migraine and preventive treatment of episodic migraine in adults.
Healthline

New Oral Treatment Approved for IBS-C

Tenapanor (Ibsrela) is an FDA-approved medication designed to help manage irritable bowel syndrome with constipation (IBS-C) when other treatments aren’t effective. The medication increases water ...
Nasdaq

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

IRVINE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, is excited to announce a major enhancement to its inFoods® ...
AOL

This Unexpected Type Of Treatment May Be A Surefire Way To Improve Your IBS Symptoms

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." When I hear the word hypnosis, I picture an auditorium of people lulled into a zombie-like state with a ...